especially pancreatic ductal adenocarcinoma tends to be with bad prognosis due to higher grade malignancy and metastasis. Formerly researches suggested that cancer stem cells play an important part in the initiation and process of pancreatic cancer
so that
well understanding on the mechanism of pathogenesis will contribute to a direct treatment on it. Complex signal pathways and transcription factors determined the differentiation of precursor cells during the development of pancreas
whereas
also involved in pancreatic malignant changes
which could be used as markers tracking cancer stem cells. Moreover
several special proteins were also employed as tools for pancreatic cancer stem cells screening. In this text
we reviewed origination and identification of pancreatic cancer stem cells
Targeted therapy and immunotherapy combined with chemotherapy bring effective response to AFP positive colon cancer patients: a case report and literature review
Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives
Research status and progress of third-line treatment for metastatic colorectal cancer
Impact of miR-193a-3p on migration and invasion of breast cancer stem cells through targeting TRIM14
Effectiveness and safety analysis of camrelizumab combined with chemotherapy and targeted therapy in patients with recurrent, metastatic, and treatment-naive advanced cervical cancer: a retrospective cohort study
Related Author
LIU Miao
LI Jinze
WU Chensi
ZHANG Fengbin
GAO Hongsheng
ZHANG Ruixing
LU Ye
ZHANG Wenxiang
Related Institution
Department of Pathology, the Fourth Hospital of Hebei Medical University
Department of Gastroenterology, the Fourth Hospital of Hebei Medical University
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital& Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Oncology, The First Affiliated Hospital of Naval Medical University